Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0000899243-19-028543

Options or other derivatives

  • Chief Scientific Officer acquired 64,241 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Loose Christopher R. · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-12-03 Grant or award : show line 1 in the form Stock Option +64,241 $3.37 2029-04-16 64,241 64,241 D
Loading xslF345X03/doc4.xml…